HEROIN ADDICTION IN ADOLESCENTS IS ASSOCIATED WITH COGNITIVE DECLINE AND VARIATIONS IN BDNF LEVELS
Main Article Content
Keywords
Abstract
Heroin addiction among adolescents is a growing public health concern with profound implications on brain function and cognitive performance. Brain-Derived Neurotrophic Factor (BDNF) plays a critical role in neurodevelopment, synaptic plasticity, and cognitive function in adolescents. This study investigates the relationship between heroin addiction, cognitive decline, and serum BDNF expression levels in adolescent subjects.
Methods: A total of 84 adolescent participants were enrolled and divided into three groups: Group 1 (Control; n=28), comprising individuals with no history of addiction; Group 2 (Treated Heroin Addicts; n=28), consisting of subjects undergoing treatment; and Group 3 (Untreated Heroin Addicts; n=28), comprising active users without medical intervention. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA). Serum BDNF levels were analyzed through Western blotting using BDNF-specific antibodies. All experiments were conducted at the Centre for Advanced Studies in Vaccinology and Biotechnology (CASVAB), Quetta, Balochistan.
Results: Group 3 exhibited significantly lower MoCA scores compared to Groups 1 and 2 (p<0.001). BDNF protein levels were markedly decreased in untreated heroin addicts (Group 3), while partial restoration of BDNF expression was observed in the treated group (Group 2). Statistically significant differences in BDNF expression were observed across the three groups (p<0.01).
Conclusion: Heroin addiction in adolescents is associated with marked cognitive deficits and reduced BDNF expression. Therapeutic intervention appears to mitigate some of these effects, highlighting the potential of BDNF as a biomarker for cognitive recovery. Early detection and intervention are critical for preventing long-term neurocognitive damage in addicted adolescents.
References
2. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002;67(1):41-51.
3. Squeglia LM, Jacobus J, Tapert SF. The influence of substance use on adolescent brain development. Clin EEG Neurosci. 2009;40(1):31-38.
4. Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14(6):401-416.
5. Kim DJ, Roh S, Kim Y, Yoon SJ, Choi J, Hwang J. Decreased plasma BDNF levels in patients with alcohol dependence. Alcohol Clin Exp Res. 2005;29(7):1168-1172.
6. Phillips JL, Batten LA, Tremblay P, Alda M, Blier P. A Prospective, Longitudinal Study of BDNF in Response to Electroconvulsive Therapy. Biol Psychiatry. 2019;85(10):e45-e47.
7. Zhao Y, Li X, Chen X, Ma S, Chen R, Zhang J. Chronic heroin exposure impairs hippocampal neurogenesis and memory function by modulating microglial polarization in adolescent rats. Neuropharmacology. 2022;207:108944.
8. Alipour A, Jafari Z, Soltani Z, Salmani ME. Cognitive impairments in patients with opioid dependence: A systematic review and meta-analysis. Addict Health. 2021;13(2):100–9.
9. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, et al. BDNF signaling in learning and memory. Cold Spring Harb Perspect Biol. 2020;12(6):a033119.
10. Ghazizadeh-Hashemi SA, Hasani M, Aslani M, Tavakkoli H, Dehghan F, Saadat H, et al. Methadone maintenance therapy and its effects on BDNF serum levels and cognitive performance in opioid-dependent patients: A clinical study. Subst Abuse Treat Prev Policy. 2023;18(1):15.
11. Tang YY, Posner MI, Rothbart MK. Neural correlates of mindfulness meditation: A review of current research. Neurosci Biobehav Rev. 2021;121:129–38.
12. Ranjbaran Z, Alaei H, Hosseini-Sharifabad A, Iloun S, Sadeghian R. The effect of aerobic exercise on BDNF and cognitive performance in adolescent rats exposed to morphine. Physiol Behav. 2020;225:113089.
13. Noda Y, Setoyama D, Asada T. Resilience and BDNF: Exploring potential therapeutic targets for recovery from adolescent substance abuse. Neurosci Res. 2021;168:70–6.
14. McNamara RK, Abel T, Jandacek R, Rider T, Tso P. Omega-3 fatty acid supplementation enhances cognitive function and increases BDNF levels in opioid-exposed adolescent rats. Brain Res. 2021;1764:147421.
15. Sinha R, Lacadie CM, Constable RT, Seo D. Effects of cognitive behavioral therapy on BDNF and stress-related neurocircuitry in adolescents with substance use disorder. J Child Psychol Psychiatry. 2022;63(4):428–37.
16. Baum KT, Desai A, Field J, Miller LE. Structured sleep intervention improves cognitive performance and BDNF levels in substance-using adolescents. Sleep Med. 2020;75:270–7.
17. Yu Q, Zhang R, Deng Z, Hu Y, Guo Q. White matter microstructure disruptions in adolescents with heroin dependence: A diffusion tensor imaging study. Addict Biol. 2023;28(1):e13208.
18. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl). 2020;201(3):435–42.
19. Dwivedi Y. Evidence demonstrating role of BDNF in depression and antidepressant response. Asian J Psychiatr. 2022;70:102997.
20. Sun Y, Huang Z, Liu C, Zhang X, Gong L. Chronic heroin use promotes inflammation and downregulates BDNF in adolescent brain: implications for neurodevelopment. Brain Behav Immun. 2021;95:82–90.
21. Tripathi A, Kashyap A, Jha S. Role of anti-inflammatory therapy in opioid-related cognitive dysfunction: a translational perspective. Neurotherapeutics. 2023;20(2):366–79.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Zunera Tanveer
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan
Department of Physiology, Bolan Medical College, Quetta, Pakistan
Muhammad Rafiq
Lahore School of Behavioral Sciences, The University of Lahore, Lahore, Pakistan
Irfan Shahzad Sheikh
Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Hafiz Muhammad Ali
Faculty of Veterinary and Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Tahir Maqbool
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan
Tauseef Muhammad Asmat
Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Asad Ullah
Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
Syed Zeeshan Haider Naqvi
Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan